Please Join AAPS PPSTDD Community Webinar "De-risking Your Drug Combination Product Development with Data Driven Results" presented by Robert Schultheis on Wednesday, June 26, from 12:00-1:00 pm EST.
Robert Schultheis is currently a Principal Combination Product Consultant at ZebraSci/BD
Drug Combination Product development requires a deep understanding of the components to the overall system to ensure the safe and efficient delivery of the drug.
Main challenges that impact pre-filled syringes (PFS) product development are:
• Drug-Container Interaction
• Mechanical Performances
• Container Closure Integrity
Robert's presentation will focus on the tools & methodology can be deployed to anticipate such challenges and provide key data to de-risk your drug combination product development at an early stage.
• Introduce the predictive tools & methods for an early assessment of drug-container interaction and mechanical performance to de-risk your Drug Combination Product development
• Present a case study of how these tools can be used to make data driven decisions about PFS and Autoinjector device selection
Please feel free to reach out here or via email if you have questions.
AAPS PPSTDD Webinar "De-risking Your Drug Combination Product Development with Data Driven Results"
Jun 26, 2023, 12:00 – 1:00 PM (America/New_York)
Please join my meeting from your computer, tablet or smartphone.
https://meet.goto.com/684726589
You can also dial in using your phone.
Access Code: 684-726-589
United States: +1 (571) 317-3122
Join from a video-conferencing room or system.
Meeting ID: 684-726-589
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Or dial directly: [email protected] or 67.217.95.2##684726589
Get the app now and be ready when your first meeting starts:
https://meet.goto.com/install
------------------------------
Yuan Cheng PhD
Senior Principal Scientist
Regeneron Pharmaceuticals
Tarrytown NY
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------